EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy

Valeria Runfola, Roberto Giambruno, Claudia Caronni, Maria Pannese, Annapaola Andolfo, Davide Gabellini

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.113120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Valeria Runfola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gene Expression and Muscular Dystrophy Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy. Hauptthemen laut MEDLINE: Homeodomain Proteins, Muscular Dystrophy, Facioscapulohumeral. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Homeodomain ProteinsMuscular Dystrophy, FacioscapulohumeralHumansAmyotrophic Lateral SclerosisGene Expression RegulationGenes, HomeoboxMuscle, SkeletalNeurodegenerative DiseasesNuclear Matrix-Associated ProteinsRNA-Binding Proteins

Stichwörter der Autor:innen

ALSCP: Developmental biologyDUX4FSHDcell toxicitygene regulationmuscle differentiation

Substanzen

Homeodomain ProteinsMATR3 protein, humanNuclear Matrix-Associated ProteinsRNA-Binding Proteins

Autor:innen und Institutionen

  • Gene Expression and Muscular Dystrophy Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
  • Gene Expression and Muscular Dystrophy Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Te…
  • ProMeFa, Proteomics and Metabolomics Facility, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
  • Gene Expression and Muscular Dystrophy Unit, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy. Electronic address: gabellini.davide@hsr.it.

Förderung

  • NCI NIH HHS
  • Ministero della Salute
  • Associazione Italiana per la Ricerca sul Cancro
  • National Institutes of Health
  • Fondazione Italiana per la Ricerca sul Cancro Airc
  • National Cancer Institute
  • University of Rochester
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Runfola, V., Giambruno, R., Caronni, C., Pannese, M., Andolfo, A., & Gabellini, D. (2023). MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113120

Vancouver

Runfola V, Giambruno R, Caronni C, Pannese M, Andolfo A, Gabellini D. MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113120

BibTeX
@article{Runfola2023,
  author = {Runfola, Valeria and Giambruno, Roberto and Caronni, Claudia and Pannese, Maria and Andolfo, Annapaola and Gabellini, Davide},
  title = {MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.113120}
}
Kostenlos starten →